Share
 
Title
Code
Session Type
Channel
Date Time
Chair:

Optimizing adherence to antiretrovirals (for both treatment and prevention) is essential to slowing the spread of HIV. This session looks at what we know, and what we still have to learn, about medication adherence, and how lessons from other health conditions can inform PrEP adherence approaches; includes consumer and provider perspectives on PrEP adherence; and reviews state of the art approaches to PrEP adherence monitoring.

SY05.01 Context setting for what is adherence within and outside HIV
Robert HORNE, UCL School of Pharmacy, United Kingdom
SY05.02 User perspective (to give voice to a range of perspectives)
Gcobisa MADLOLO, South Africa
Slides
SY05.03 The provider dilemma: What's not in the guidelines
Andrew GRULICH, The Kirby Institute, Australia
Slides

SY05.04 Metrics of monitoring: What it can and can't tell you
Monica GANDHI, University of California, San Francisco, United States
Slides
SY05.06 Live Q&A